Biosimilars to antitumor necrosis factor agents in inflammatory bowel disease

E Al Sulais, T AlAmeel - Biologics: Targets and Therapy, 2020 - Taylor & Francis
Abstract Anti-tumor Necrosis Factor (anti-TNF) agents are the backbone treatment of
moderate to severe cases of inflammatory bowel disease. One of the main drawbacks of …
被引用次数：11 相关文章

Biosimilars to Antitumor Necrosis Factor Agents in Inflammatory Bowel Disease.

E Al Sulais, T AlAmeel - Biologics: Targets and Therapy, 2020 - go.gale.com
Anti-tumor Necrosis Factor (anti-TNF) agents are the backbone treatment of moderate to
severe cases of inflammatory bowel disease. One of the main drawbacks of these agents is …
[HTML] nih.gov

[HTML][HTML] Biosimilars to Antitumor Necrosis Factor Agents in Inflammatory Bowel Disease

E Al Sulais, T AlAmeel - Biologics: Targets & Therapy, 2020 - ncbi.nlm.nih.gov
Abstract Anti-tumor Necrosis Factor (anti-TNF) agents are the backbone treatment of
moderate to severe cases of inflammatory bowel disease. One of the main drawbacks of …

Biosimilars to Antitumor Necrosis Factor Agents in Inflammatory Bowel Disease

E Al Sulais, T AlAmeel - Biologics: Targets and Therapy, 2020 - dovepress.com
Anti-tumor Necrosis Factor (anti-TNF) agents are the backbone treatment of moderate to
severe cases of inflammatory bowel disease. One of the main drawbacks of these agents is …

Biosimilars to Antitumor Necrosis Factor Agents in Inflammatory Bowel Disease

E Al Sulais, T AlAmeel - Biologics: targets & therapy, 2020 - pubmed.ncbi.nlm.nih.gov
Anti-tumor Necrosis Factor (anti-TNF) agents are the backbone treatment of moderate to
severe cases of inflammatory bowel disease. One of the main drawbacks of these agents is …

Biosimilars to Antitumor Necrosis Factor Agents in Inflammatory Bowel Disease

E Al Sulais, T AlAmeel - Biologics, 2020 - search.proquest.com
Abstract Anti-tumor Necrosis Factor (anti-TNF) agents are the backbone treatment of
moderate to severe cases of inflammatory bowel disease. One of the main drawbacks of …

Biosimilars to Antitumor Necrosis Factor Agents in Inflammatory Bowel Disease.

E Al Sulais, T AlAmeel - Biologics: Targets & Therapy, 2020 - europepmc.org
Abstract Anti-tumor Necrosis Factor (anti-TNF) agents are the backbone treatment of
moderate to severe cases of inflammatory bowel disease. One of the main drawbacks of …